Biol Reprod Keystone Symposia Conference on Frontiers in Reproductive Biology & Regulation of Fertility.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print October 26, 2005.
Biol Reprod 2005, 10.1095/biolreprod.105.046169
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
74/2/395    most recent
biolreprod.105.046169v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tatone, C.
Right arrow Articles by Amicarelli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tatone, C.
Right arrow Articles by Amicarelli, F.
Agricola
Right arrow Articles by Tatone, C.
Right arrow Articles by Amicarelli, F.
BIOLOGY OF REPRODUCTION 74, 395–402 (2006)
DOI: 10.1095/biolreprod.105.046169
© 2006 by the Society for the Study of Reproduction, Inc.


Research Article

Age-Associated Changes in Mouse Oocytes During Postovulatory In Vitro Culture: Possible Role for Meiotic Kinases and Survival Factor BCL21

Carla Tatone 2 34 , Maria Cristina Carbone 5, Rita Gallo 6, Simona Delle Monache 3, Mario Di Cola 3, Edoardo Alesse 6, and Fernanda Amicarelli 5

Department of Biomedical Sciences and Technologies,3 Center for Assisted Reproduction,4 Department of Basic and Applied Biology,5 Department of Experimental Medicine,6 University of L'Aquila, 67100 L'Aquila, Italy

ABSTRACT

To elucidate molecular mechanisms underlying oocyte senescence, we investigated whether oocytes from female mice of advanced reproductive age exhibit a precocious postovulatory aging that, in turn, may be responsible for the precocious activation of an apoptotic program. During a 9-h in vitro culture, the frequency of oocytes showing MII aberrations, spontaneous activation, and cellular fragmentation increased in old oocytes (P < 0.05), whereas it did not change in the young group. In old oocytes, the activities of MPF (a complex of the cyclin-dependent kinase cdc2 and cyclin B1) and MAPK (mitogen-activated protein kinase) decreased precociously, showing a first drop as early as 3 h after the beginning of in vitro culture (P < 0.05). Immunoblotting and immunocytochemical analysis revealed that, in oocytes of the old group, reduction of BCL2 expression at protein level occurred earlier than in the young group (P < 0.05) and was not associated to the loss of BCL2 transcripts detected by RT-PCR. These changes are followed by an abrupt increase of the rate of TUNEL-positive oocytes after 24 h of culture to a value of 67% ± 6%. Exposure of young oocytes to 20 µM roscovitine or 20 µM U0126, specific inhibitors of MPF and MAPK, resulted in the decreased percentage of oocytes showing positive immunostaining for BCL2 and in an increased rate of DNA fragmentation. Present results suggest that the developmental competence of oocytes ovulated by aging mice may be negatively influenced by a downregulation of MPF and MAPK activities that in turn induces the activation of a proapoptotic signaling pathway.

aging, apoptosis, fertilization, kinases, oocyte development

INTRODUCTION

Aging-related decline in female fertility is a common feature in females from most mammalian species, including humans. In women, reproductive senescence becomes clinically significant by the late 30s, ending in complete loss of fertility by the late 40s, even though there are still primary oocytes within the ovary [1]. Although age affects nearly every aspect of female reproduction, the oocyte is believed to be a major locus of reproductive aging. Besides reduction in terms of number of follicles, age is also responsible for a reduced oocyte quality, which refers to the oocyte ability to be fertilized and undergo normal embryo development [2]. The most direct evidence for oocyte senescence in humans is the finding that oocytes donated from young to older women in assisted-reproduction programs abrogate the effects of age on fertility [3]. However, how age affects the inherent features of the oocyte that determine its developmental potential is still poorly understood. It has been well recognized that oocyte aneuploidy is significantly increased with maternal age, mostly due to errors in chromosome segregation at the first meiotic division [4]. Also, anomalies in the meiotic spindle have been described and most likely contribute to the chromosome misalignment evidenced at both metaphase I and metaphase II [5]. Although these errors are passed on to monosomic and trisomic embryos and compromise embryo viability, an increase of euploid embryo abortuses has been observed during female aging. Moreover, in mice, the relationship between oocyte aneuploidy rate and aging-associated decrease in fertility remains still controversial [6–9], supporting the idea that, beyond nuclear defects, abnormalities in the ooplasm may also impact on embryo development during reproductive aging.

In human oocytes, cytoplasmic aging has been associated with decline of mitochondrial functions, reduced content of transcripts from genes participating in spindle assembly checkpoint and increased frequency of apoptosis [10–12]. Similar age-related changes have been described in the mouse model, where a low fertilization competence has been related to oocyte abnormalities, including chromosome scattering, chromosome decondensation, alteration of gene expression pattern, and high rates of DNA fragmentation [13–15]. It is important to mention that some oocyte defects associated with maternal aging seem to resemble changes occurring during postovulatory aging in oocytes from young females [16, 17]. It is well known that the ovulated mature oocyte has a short life-span associated with a time-dependent decrease of its normal developmental competence after ovulation, so that delayed fertilization frequently fails or even causes long-term effects on conceptuses [16, 18]. Beyond cellular modifications, changes occurring after ovulation include the spontaneous decrease of the activities of critical enzymes involved in the maintenance of the meiotic arrest of oocytes at metaphase II (MII) [19–21]. MII-arrested oocytes exhibit a characteristic high activity of maturation promoting factor (MPF), a complex of activated cdc2 kinase (CDK1) and cyclin B that maintains MII state [22]. In addition to MPF, MII-arrested oocytes are also characterized by high activity of mitogen-activated protein kinase (MAPK)3/MAPK1 (also known as ERK1/ERK2). MAPK is a component of the cytostatic activity (CSF) that maintains MII arrest [23]. In order for fertilization to succeed, the oocytes must keep high MPF and MAPK activities and inactivate them, upon sperm penetration, in a coordinated, step-wise fashion. Therefore, downregulation of the molecular mechanisms that control MII can compromise normal entry into embryonic cell cycle following fertilization. A further biochemical change associated with postovulatory aging is the decreased expression of BCL2, an antiapoptotic regulator of the BCL2 family [21, 24]. BCL2 protein localizes in the outer mitochondrial membrane, nuclear membrane, and endoplasmic reticulum and regulates mitochondrial function, Ca2+ homeostatis, and cell survival [25, 26]. A reduced BCL2 activity may be responsible for the altered balance between survival and death-promoting factors, leading to programmed cell death in oocytes skipping or delaying sperm encounter, as occurs in somatic cells [27].

To elucidate molecular mechanisms underlying oocyte senescence, we investigated whether oocytes from females in advanced reproductive age exhibit a precocious postovulatory aging that, in turn, may be responsible for the precocious activation of an apoptotic program. In this study, we used the mouse model to compare the time-course of biochemical and cellular changes occurring during postovulatory in vitro culture in oocytes obtained from young and old animals. Then, to elucidate the possible role of MPF and MAPK in regulating oocyte survival, we studied whether treatment of oocytes from young mice with MPF and MAPK inhibitors can induce a decrease of BCL2 protein and an increased rate of DNA fragmentation.

MATERIALS AND METHODS

Oocyte Collection and Treatment

CD-1 mice were obtained from Charles River Italia s.r.l. (Calco, Italy). Animal care and experiments were carried out in accordance with the Guide for Care and Use of Laboratory Animals (1996). At the age of 4–8 wk (young mice) and 48–52 wk (old mice), females were superovulated by intraperitoneal injection of 10 IU of eCG (Folligon; Intervet-International, Boxmeer, Holland) and 10 IU of hCG (Profasi HP 2000; Serono, Roma, Italy) 48 h apart. MII-arrested oocytes were released at 15 h post-hCG from the oviducts into the medium M2 (Sigma, St. Louis, MO). Cumulus cells were dispersed by a brief exposure to 0.3 mg/ml hyaluronidase (Sigma) and oocytes were pooled and randomized before distribution into the experimental groups. Oocytes were processed immediately or cultured at 37°C, 5% CO2 in M16 medium (Sigma) for various times. For brevity, oocytes from animals of the two groups of age are called young oocytes and old oocytes. The mean ± SEM of oocytes ovulated per female were the following: 20.86 ± 1.76 young oocytes and 8.84 ± 1.18 old oocytes (P < 0.001, Student t-test).

MPF and MAPK Activity Assay

For kinase activity assays, nonfragmented oocytes (five for each experimental group, two replicates) were transferred to centrifuge tubes in 2 µl of collection buffer (PBS containing 1 mg/ml polyvinil alcohol, 5 mM EDTA, 10 mM Na3VO4, 10 mM NaF), immediately submerged in liquid N2, and stored at –80°C until the kinase assay was performed. The frozen oocytes were thawed in 4 µl of reaction mixture containing ß-glycerophosphate 54 mM, paranitrophenylphosphate 14.5 mM, morpholenepropanesulfonic acid 24 mM, MgCl2 14.5 mM, EGTA 14.5 mM, EDTA 0.12 mM, DTT 1 mM, leupeptin 1 µg/ml, aprotinin 1 µg/ml, ML-9 10 µM, genestein 75 µM, chimostatin 1 µg/ml, trypsin-chimotrypsin inhibitor 1 µg/ml, PKI 2,4 µM, 50 µCi/ml {gamma}-[32P] ATP (Amersham Pharmacia Biotech, Uppsala, Sweden). To the reaction mixture were added histone H1 type III-S and myelin basic protein (MBP), specific substrates, respectively, of MPF and MAPK. The reagents for the collection buffer and the reaction mixture were obtained from Sigma. After 30 min at 37°C, assays were stopped by adding sample buffer 1:1 [28] and proteins in oocytes were denaturated by heating the reaction mixture at 95°C for 5 min. Samples were electrophoresed on 12% SDS polyacrylamide gels that were subjected to autoradiography. Autoradiographs were scanned and densitometric values for each treatment group were measured by the Adobe Photoshop software (Mountain View, CA). Values in each autoradiograph were standardized by setting oocytes from young mice at the beginning of in vitro culture (time 0) as 100% activity.

Analysis of Chromosomal Distribution, DNA Organization, and Cellular Morphology

The morphological appearance of oocytes was examined under a stereoscope microscope. Degenerated oocytes were discarded and the presence of oocytes with cellular fragmentation were evaluated. Chromosomal distribution and DNA organization were evaluated by DNA staining. Briefly, oocytes immediately recovered or cultured for different times in M16 medium at 37°C, 5% CO2 were fixed in 3.7% paraformaldehyde in PBS and then incubated with 3 µg/ml Hoechst 33342 (Sigma). Oocytes were mounted onto a slide under a coverslip in a mounting medium (glycerol 50%) and observed under an epifluorescence microscope with a 100x objective (Leitz Dialux with filter BP 340–380). A filter with an excitation wavelength of 330–380 nm and barrier filter of 420 nm was used to detect chromatin of oocytes stained by Hoechst 33342. Anomalies in the distribution of chromosomes in the MII spindle and DNA organization were classified as follows: 1) chromosome scattering if one or more chromosomes were separated from the metaphase plate and 2) chromosome decondensation if chromosomes showed varying degrees of DNA condensation. Oocytes showing anaphase-II or telophase-II configurations were considered activated.

Reverse Transcription and Polymerase Chain Reaction

Oocytes were washed in PBS containing 3 mg/ml polyvinylpyrrolidone (PBS-PVP) and transferred into a 0.6-ml tube in a volume less then 2 µl. Oocytes were immediately subjected to thermolysis and reverse transcription (RT) by means of cell-to-cDNA kit (Ambion Inc., Austin, TX), according to the manufacturer's instructions. Polymerase chain reaction (PCR) analyses were carried out in 50 µl containing the cDNA equivalent of 15 oocytes, PCR buffer 1x (Perkin Elmer Life And Analytical Sciences, Boston, MA), 1.5 mM MgCl2, 0.2 mM of each dNTP, 0.2 µM of each primer, and 1.25 U of Taq polymerase (all products from Perkin Elmer). Actb (beta-actin) was selected as a housekeeping gene. Primer sequences for beta-actin were derived from the published complementary DNA sequences provided by GenBank (Accession GI 38648901): 5'GTACCCCATTGAACACGGCA and 3'GCACAGTGTGGGTGACCCC. The beta-actin cDNAs were amplified for 35 cycles with the following profile: 94°C for 10 min for 1 cycle; 94°C for 50 sec, 60°C for 50 sec, 72°C for 1 min for 35 cycles; 72°C for 10 min. Only cDNA samples positive for beta-actin were processed for Bcl2 cDNA amplification. Primers sequences for BCL2 were derived from the published complementary DNA sequences provided by GenBank [29] (Accession M16506, L31532): 5'TACCGTCGTGACTTCGCAGAG and 3'GGCAGGCTGAGCAGGGTCTT. The Bcl2 cDNAs were amplified for 40 cycles with the following profile: 96°C for 1 min for 1 cycle; 96°C for 1 min, 56°C for 1 min, and 72°C for 15–25 sec for 2 cycles; 94°C for 1 min, 59°C for 1 min, 72°C for 15–25 sec for 18 cycles; then 94°C for 1 min, 59°C for 30 sec, 72°C for 15–25 sec plus 1 sec per cycle for 20 cycles. After amplification, the RT-PCR products were separated by agarose (1.5%) gel electrophoresis, stained by ethidium bromide, and visualized under UV.

Western Blot Analysis

Three hundred oocytes for each experimental group were lysed in sample buffer. As a positive control, microsomes from mouse ovaries were used as previously described [24]. Briefly, tissue samples were homogenized in 0.3 M sucrose, 1 mM EDTA, 1 mM 2-mercaptoethanol, 0.1 mM PMSF, 2 µg/ml pepstatin, 2 µg/ml leupeptin, 50 mM Tris-HCl (pH 8.0; all chemicals from Sigma) and centrifuged at 2500 x g for 15 min. The supernatant was centrifuged at 100000 x g for 30 min. The microsomal precipitates were resuspended in 0.3 M sucrose, 1 mM EDTA, 1 mM 2-mercaptoethanol, 50 mM Tris-HCl (pH 8.0) and electrophoresed with oocytes samples onto 12% SDS-polyacrylamide gels. The resolved proteins were blotted onto nitrocellulose membranes, which were repeatedly washed in 10 mM Tris-HCl (pH 8), 150 mM NaCl, 0.05% Tween-20 (TBS-T). The membranes were then blocked in TBS-T supplemented with 6% (w/v) nonfat dry milk and then probed for BCL2 by incubation overnight at 4°C with an anti-BCL2 rabbit polyclonal antibody (1:400; Calbiochem, La Jolla, CA). After several washes in TBS-T, the membranes were incubated in a 1:3000 dilution of goat anti-rabbit secondary horseradish peroxidase-coupled antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) in TBS-T for 1 h. The same blot was first probed with antibody to BCL2, then stripped and reprobed with anti-ACTB (beta-actin) rabbit polyclonal antibody (1:500; Sigma). The specific antibody binding was detected by using the enhanced chemiluminescence system according to the manufacturer's instructions (Amersham Biosciences, Little Chalfont, England). Autoradiographs were scanned and semiquantification of immunoreactive BCL2 was done using Adobe Photoshop 4.0. The intensity of the BCL2 bands in each autoradiograph was expressed relative to the intensity of the band in young oocytes processed at the beginning of in vitro culture (time 0).

Confocal Microscopy

Oocytes from each experimental group were exposed for about 1 min to Tyrode solution [30] to remove zona pellucida. Zona-free oocytes were fixed as above described, permeabilized for 5 min in 0.1% TritonX-100 in PBS-PVP, and washed in blocking buffer (PBS-PVP, 0.1% BSA, 0.01% Tween-20). Permeabilized oocytes were incubated with the BCL2 polyclonal antibody (1:100) for 1 h at room temperature, followed by incubation with 1:800 dilution of a secondary anti-rabbit IgG conjugated with Cy-3 (Molecular Probes, Eugene, OR). In each experiment, negative control samples in which the primary antibody was omitted were also evaluated. After washing in blocking solution, oocytes were treated with an antibleaching solution (Slow-Fade; Molecular Probes), mounted on a glass slide, and sealed with clear nail polish. Oocytes were observed using an Olympus FV500 confocal microscope equipped with a laser Green Helium-Neon (543 nm) and a PLAN-APO 60/1.4 oil objective (Olympus Optical Co. Gmbh, Hamburg, Germany).

Detection of Apoptosis by TUNEL Assay

DNA fragmentation was detected by TUNEL method by means of in situ cell death kit (Roche Diagnostic Gmbh, Mannheim, Germany). The oocytes were fixed and permeabilized as above described. Positive control was represented by young oocytes treated with 50 U/ml DNase. The experimental groups and positive control group were incubated at 37°C for 1 h in 25 µl of TUNEL reaction mixture containing dUTP-fluorescein isothiocyanate (FITC), terminal deoxynucleotydil transferase (TdT) enzyme, and reaction buffer. Negative control was represented by young oocytes incubated in TUNEL reaction mixture without dUTP-transferase enzyme. After washing three times in PBS-PVP, the oocytes were incubated in Hoescht 33342 at room temperature and mounted on slides. The samples were observed using an epifluorescence microscope at 400x magnification. Two standard filter sets were used, a filter with an excitation wave length of 450–490 nm and a barrier filter of 520 nm were used to detect FITC alone. A filter with an excitation wavelength of 330–380 nm and a barrier filter of 420 nm were used to detect the nuclear status of oocytes stained with Hoechst 33342. Oocytes were considered TUNEL-positive when Hoechst33342 staining was associated with FITC staining.

Roscovitine and U0126 Treatments

Roscovitine and U0126 (Calbiochem) were prepared as 25 mM stock solutions in DMSO and stored at –20°C until use. Oocytes from young mice were transferred in M16 medium containing 20 µM roscovitine or 20 µM U0126. For control treatments, oocytes were cultured in M16 containing 0.05% DMSO.

Statistical Analysis

Values were compared using one-way ANOVA and Student t-test. Multiple comparison of values was carried out using Student-Newman-Keul test. All analyses were performed using the SigmaStat software (Jandel Scientific Corporation, San Rafael, CA). Statistically significance was reached at P < 0.05.

RESULTS

MII Aberrations, Spontaneous Activation, and Cellular Fragmentation in Old Oocytes During Postovulatory In Vitro Culture

In the first set of experiments, we compared, in young and old oocytes, the ability to maintain a normal MII configuration during postovulatory in vitro culture. To this end, we monitored the presence of oocytes with abnormal MII or spontaneously activated after different times of in vitro culture. As shown in Figure 1A, when cells were scored for the presence of abnormal MII at the beginning of in vitro culture, old oocytes exhibited a frequency of this pattern higher than that monitored in young oocytes (P = 0.022). Subsequent in vitro culture resulted in an abrupt increase of this alteration in old oocytes (time 0 vs. time 3 h, P = 0.014), whereas it had only a slight, but not significant, effect on young oocytes (P = 0.3). Moreover, in the old group, the percentage of oocyte activation increased from a value of 7.38 ± 4 to 22.75 ± 2.12 after 9 h of culture (P = 0.04), a value about twofold higher than that observed in the young group at the corresponding time point (Fig. 1B). By contrast, the frequency of oocyte activation in the young group did not change significantly after 9 h of in vitro culture (Fig. 1B). When cellular fragmentation was assessed through morphological analysis under a phase-contrast microscopy, old oocytes revealed greater values than those observed in the young group at all time points investigated. Also, unlike the young group, where the frequency of cellular fragmentation increased slowly during in vitro culture, in old oocytes, a 9-h in vitro culture resulted in a significant increase of this pattern from 21% to 35% (P = 0.017; Fig. 1C).


Figure 1
View larger version (32K):
[in this window]
[in a new window]
 
FIG. 1. MII aberrations (A), spontaneous activation (B), and cellular fragmentation (C) in old and young oocytes cultured in vitro culture for 9 h. Fluorescence micrographs show representative examples of normal distribution of MII chromosomes in the spindle (a), two different types of decondensed chromosomes (b, c), chromosomes scattered (d), chromosomes in anaphase II configuration (e). Photographed with x100 objective; bar = 5 µm (a–e). Phase-contrast micrograph shows a representative example of an oocyte exhibiting cellular fragmentation. Photographed with x40 objective; bar = 10 µm. Data are expressed as mean ± SEM of percentages calculated in at least three independent experiments, where about 15 oocytes were observed for each time point investigated. * P < 0.05 compared with the corresponding time points in the young group

Changes of MPF and MAPK Activities in Old Oocytes During Postovulatory In Vitro Culture

We compared in old and young oocytes the time course of the spontaneous decrease of the enzymatic activities of MPF and MAPK that occurs after ovulation. The activities of MPF and MAPK, evaluated as oocyte ability to phosphorylate histone H1 and MBP substrates, respectively, were monitored following different times of in vitro culture. As shown in Figure 2, old oocytes at the beginning of in vitro culture exhibit only a slight decrease in the activities of both kinases when compared with the young group. However, as in vitro culture progressed, MPF and MAPK activities in old oocytes were significantly lower than those detected in the young group at any time point investigated (P < 0.05).


Figure 2
View larger version (16K):
[in this window]
[in a new window]
 
FIG. 2. Changes of relative MPF (A) and MAPK (B) activities in young and old oocytes cultured in vitro for 24 h. Data, which are expressed as mean ± SEM of percentages calculated in at least four independent experiments, are normalized to the activities obtained for young oocytes at the beginning of in vitro culture. Means with different letters are significantly different (P < 0.05)

In young oocytes, relative MPF activity decreased significantly after 9 h of culture (6 h vs. 9 h, P = 0.020), whereas in old oocytes, a loss of this activity could be detected as early as 3 h after the beginning of in vitro culture (0 h vs. 3 h, P = 0.047; Fig. 2A). After 24 h, MPF activity reached in old oocytes a value about half of that monitored in the young group.

As shown in Figure 2B, a first drop in relative MAPK activity occurred after 6 h of culture in young oocytes (3 h vs. 6 h, P = 0.048) and after 3 h of culture in old oocytes (0 h vs. 3 h, P = 0.025), where a second drop could be observed at 9 h (6 h vs. 9 h, P = 0.025). MAPK activity decreased further in this group, ending at 32% residual value after 24 h of culture, when young oocytes exhibited a value about twofold higher.

Effect of Postovulatory In Vitro Culture on BCL2 Expression and DNA Fragmentation in Old Oocytes

It is known that expression of the survival factor BCL2 at RNA and protein level is spontaneously impaired during postovulatory in vitro culture in the presence of constant levels of Bax transcripts [24]. Then, it is possible that the susceptibility to spontaneous apoptosis of old oocytes [15] correlates with a reduced expression of BCL2. To accomplish this, we monitored the presence of Bcl2 mRNA in oocytes from young and old mice, soon after their collection and after 9 h of in vitro culture. RT-PCR experiments showed that old oocytes, similarly to young oocytes, still maintained detectable levels of Bcl2 transcripts at least until 9 h from the beginning of in vitro culture (Fig. 3).


Figure 3
View larger version (41K):
[in this window]
[in a new window]
 
FIG. 3. RT-PCR analysis of Bcl2 in young and old oocytes at the beginning (0 h) or after 9 h of in vitro culture. Actb was used as a housekeeping gene. The RT-PCR assays were performed five times and shown is a representative experiment

Then, protein levels of BCL2 were monitored by means of immunoblotting and immunocytochemistry. Results from Western blot analysis revealed that the levels of BCL2 protein, at the beginning of culture period, were not significantly different comparing old and young oocytes of the groups of age. However, after a prolonged in vitro culture, the level of BCL2 protein in the young group decreased significantly, to about half of the initial level, whereas in the old group, it became undetectable (Fig. 4). This trend was more clearly evident when single oocytes were analyzed by immunofluorescence with the same primary antibody used in immunoblot analysis. Confocal analysis revealed that oocytes exhibited a diffuse punctuate staining. However, by using the same confocal settings, a different intensity of fluorescence could be observed. As shown in Figure 5A, three different types of immunostaining were established: type I, high staining; type II, moderate staining; type III, negative staining (equivalent to negative control). Data in Figure 5B show that the frequency of young and old oocytes showing type I and type II staining (BCL2-positive staining) decreased more rapidly in the old group, exhibiting after 9 h of culture about 50% ± 11% of BCL2-positive oocytes (young vs. old, P = 0.027). Conversely, at this time, the young group still maintained a value not significantly different from that monitored at the beginning of the culture period (P = 0.359). After 24 h, the percentage of BCL-positive oocytes decreased from 86 ± 6 to 17 ± 9 (P = 0.004) in the old group and from 100% to 61% ±7% (P = 0.012) in the young group.


Figure 4
View larger version (30K):
[in this window]
[in a new window]
 
FIG. 4. Western blot analysis of BCL2 protein in young and old oocytes. A) Representative blot showing the expression level of BCL2 in mouse oocytes immediately after their collection (time 0) and following 24 h of culture (time 24). Ovary supernatant was used as a positive control; ACTB was used as a housekeeping protein. B) Quantification of BCL2 contents in young and old oocytes. Each bar represents the mean ± SEM of two independent experiments. * P < 0.05 compared with values obtained at time 0. After a 24-h in vitro culture, BCL2 protein in the old group was undetectable


Figure 5
View larger version (42K):
[in this window]
[in a new window]
 
FIG. 5. Detection of BCL2 in young and old mouse oocytes by immunocytochemistry and confocal laser scanning microscopy. A) Representative photographs showing three different types of immunostaining observed by analysis of an optical section of 1 µm taken at equatorial level: type I, high staining; type II, moderate staining; type III, negative staining. Bar = 10 µm. B) Histogram showing the frequency of young and old oocytes showing type I and type II staining (BCL2-positive staining). Data represent mean ± SEM of percentages calculated in at least three independent experiments, where about 15 oocytes were observed for each time point investigated. Means calculated in the old group after 9 and 24 h of culture were significantly different from the means obtained at the relative time points in the young group (P < 0.05)

To relate these changes with the activation of an apoptotic pathway, we monitored DNA fragmentation during in vitro culture in the two groups of age. We found that all fragmented oocytes displayed FITC-fluorescent chromatin in at least one oocyte fragment (Fig. 6A). Unlike the young group, where the rate of TUNEL-positive oocytes increased with a slow time course from 5% ± 4% to 18% ± 4%, in the old group, most of oocytes entered the final stage of apoptosis by 24 h, when the percentage of TUNEL-positive oocytes increased from to 14% ± 5% at time 0 to 67% ± 6% (Fig. 6B).


Figure 6
View larger version (55K):
[in this window]
[in a new window]
 
FIG. 6. DNA fragmentation in young and old oocytes. A) Micrographs of a representative old oocyte positively stained for DNA fragmentation using the TUNEL method: a) phase-contrast image; b) blue fluorescence (Hoechst33342), indicating DNA; c) greenish-blue fluorescence (fluorescein), indicating fragmented DNA. Photographed with x40 objective. Original magnification x500. B) Frequency of TUNEL-positive oocytes in the young and old group. Data represent mean ± SEM of percentages calculated in three independent experiments, where about 15 oocytes where observed for each time point investigated. *P < 0.05 compared with the corresponding time points in the young group

Effects of MPF and MAPK Inhibitors on MII Configuration, BCL2 Protein Level, and DNA Fragmentation in Young Oocytes

We tested the hypothesis that perturbation of MPF and MAPK activities in oocytes from young mice may cause destabilization of metaphase arrest and chromosomal configuration and a decrease of BCL2 protein. To this end, we have used U0126, a specific inhibitor of the MAP kinase cascade [31], and roscovitine, an inhibitor of CDK1 [32], to negatively affect MAPK and MPF activities in young oocytes, as previously described [33]. To this end, we exposed oocytes from young mice to low doses of the inhibitors (20 µM roscovitine or 20 µM U0126) for 9 h. After 3 and 9 h from the beginning of incubation, oocytes were scored for the presence of abnormal MII configuration. After 9 h of culture, about 40% of U0126-treated oocytes exhibited abnormal MII configuration related to the presence of chromosomes scattered and/or decondensed. Conversely, the percentage of roscovitine-treated oocytes with abnormal MII configuration was not significantly different from that of the control group (Fig. 7A). As expected, both the inhibitors induced a low but significant activation response (Fig. 7B).


Figure 7
View larger version (15K):
[in this window]
[in a new window]
 
FIG. 7. MII aberrations (A) and spontaneous activation (B) in young oocytes exposed to 20 µM roscovitine or 20 µM U0126. Data are expressed as mean ± SEM of percentages calculated in at least three independent experiments, where about 15 oocytes were observed for each time point investigated. *P < 0.05 compared with the corresponding time point and at the beginning of in vitro culture

As shown in Figure 8A, after 9 h from the beginning of treatments, both the inhibitors were found to induce a significant reduction in the rate of oocytes positive for BCL2, reaching a value of 44 ± 5 and 33 ± 5 in the roscovitine and U0126 groups, respectively. These values declined further after 24 h of culture to 16% ± 9% and 13% ± 2% in the oocytes treated with U0126 or roscovitine, respectively. Both the inhibitors induced an increase in the rate of TUNEL-positive oocytes that, after 24 h of culture, reached a value of 60% ± 2% in the roscovitine group and a value of 53% ± 5% in the U0126 group (Fig. 8B).


Figure 8
View larger version (18K):
[in this window]
[in a new window]
 
FIG. 8. BCL2 expression and DNA fragmentation in young oocytes exposed to 20 µM roscovitine or 20 µM U0126. A) Frequency of BCL2-positive oocytes after immunocytochemistry analysis; data represent mean ± SEM of percentages calculated in at least three independent experiments, where about 15 oocytes were observed for each time point investigated. Means calculated in roscovitine and U0126 group after 9 and 24 h of culture were significantly different from the means obtained at the corresponding time points in the control group (P < 0.05). B) Frequency of TUNEL-positive oocytes. Data represent mean ± SEM of percentages calculated in at least three independent experiments, where about 15 oocytes were observed for each time point investigated. Means calculated in roscovitine and U0126 group after 24 h of culture were significantly different from the means obtained at the corresponding time point in the control group (P < 0.05)

DISCUSSION

The main point about the observations reported in the present article is the following: postovulatory aging exerts a deleterious effect on oocytes ovulated from old mice. We found that, in old oocytes cultured in vitro after ovulation, both MPF and MAPK activities decreased more rapidly than in young oocytes. In parallel, we observed a more rapid increase of abnormal MII, spontaneous oocyte activation, and cellular fragmentation. This reduced ability to control MII state seems to have a strong influence on survival of old oocytes after ovulation. An increased susceptibility to fragmentation and cell death during reproductive aging has been previously described in both human and mouse oocytes [12, 15]. In our study, we found that accelerated BCL2 degradation and activation of apoptotic pathway are both associated with an accelerated decline of meiotic kinases. Moreover, by comparing results in Figures 1 and 6, it turns out that, in the old group, massive entry in the final stage of apoptosis occurred after nearly all the oocytes had lost their normal MII configuration. This temporal correlation cannot be observed in young oocytes, where postovulatory changes occurred more slowly and gradually. It is worth noting that this comparison between oocytes with different susceptibility to apoptosis is the first evidence that meiotic kinases play an important role in the regulation of oocyte survival after ovulation, as in the model proposed by Fissore et al. [17].

As reproductive aging is associated with mitochondrial dysfunctions [10], it is reasonable to conjecture that the activities of meiotic kinases or their upstream regulators decline as a result of a reduced energy supply and/or oxidative stress, as already reported [34, 35]. Nevertheless, precocious inactivation of MPF and MAPK may reflect an aging of the old oocyte before ovulation due to an accelerated meiosis I or to an asynchrony between meiosis and ovulation. Indeed, old mouse oocytes during in vitro maturation progress faster than young oocytes to first anaphase and to metaphase II [6]. This behavior could be related to defects in the meiotic machinery, as suggested by the finding that old oocytes exhibited a reduced amount of transcripts involved in cell cycle, as compared with young oocytes [14]. Moreover, a loss of coordination between the events leading to ovulation may be caused by age-associated raised basal LH level during the follicular phase that could trigger meiosis resumption before the LH surge [16].

In the present study, we show that age-related changes of BCL2 expression at protein level were not accompanied by the loss of Bcl2 transcripts. This finding further supported the view that BCL2 degradation could be due to loss of posttranslational signals that occurred in the old oocyte more rapidly than in the young oocyte. Several works in somatic cells provide evidence that survival-promoting signals targeting BCL2 may come from the cell-cycle machinery that control M phase. BCL2 contains several consensus protein kinase sites and its phosphorylation universally occurs at the G2-M phase of the cell cycle [36]. Phosphorylation of BCL2 at residues Thr-56, Thr-74, and Ser-87 prevents proteasome targeting and confers resistance against the induction of apoptosis [37]. MAPK is believed to play a major role in this process because dephosphorylation of the MAPK site Ser-87 within BCL2 triggers its ubiquitin-dependent degradation [38]. Moreover, the observation that mitotic BCL2 phosphorylation is inhibited by roscovitine suggests that CDK1 or CDK2 are involved in this process [39].

In the present study, we found that drugs that inhibit MPF and MAP kinase activities seem to mimic an aging effect because young oocytes undergo morphological and biochemical changes similar to those observed in old oocytes. We used roscovitine or U0126 at low doses to avoid the abrupt decrease in the activity of these kinases described when oocytes are exposed to concentrations of these drugs associated with a high rate of oocyte activation [33]. As expected, both the inhibitors induced a low but significant activation response and, in oocytes exposed to U0126, we also observed an increased percentage of inactivated oocytes with chromosomes scattered or decondensed. Moreover, both the inhibitors induced a precocious decrease in BCL2 protein and a significant increase in the rate of DNA fragmentation. Because we did not determine the activities of meiotic kinases, we cannot correlate the extent of downregulation of kinase activity with the effects on the oocytes. Furthermore, we are not able to identify separate roles for MPF and MAPK because these kinases modulate their activities with each other [33]. It is likely that both MPF and MAPK participate in survival-promoting signaling in the MII oocyte. Indeed, in porcine oocytes, drugs preventing spontaneous MPF decrease can prevent cellular fragmentation [40] and, in amphibian oocytes, a MAPK pathway protects them from apoptosis [41]. This conclusion is in accordance with the view that the MII state confers protection from apoptosis, increasing survival chances after ovulation [42]. Moreover, it can be speculated that MAPK is required to exert a protective role also upon release of MII arrest by accompanying the fertilized oocytes until the entry in the first embryonic cell cycle.

Beyond downregulation of MPF and MAPK, many factors can influence the oocyte developmental competence and survival after ovulation [43, 44]. Therefore, here we suggest that the cross-talk between meiotic kinases and BCL2 may play an important role in the deadly decision in oocytes where a survival disequilibria already exists. This could be the case of oocytes from aging females, where mitochondrial dysfunction and oxidative stress have arisen during their prolonged stay in the ovary and/or from a compromised oxygen supply [45]. Oxidative stress damage has been detected in the resting oocyte and follicle pool of the aged ovary [46] and reduced antioxidant defenses have been detected in the mature oocyte [47], as well as in the follicular environment of the periovulatory follicle [48].

In conclusion, the present study provides evidence that oocytes ovulated by aging females exhibit a reduced temporal window for normal fertilization because of a failure in the mechanisms that control MII state in the mature oocytes that, in turn, might result in the decay of positive signals targeted on survival factors. Such a connection between machineries that control cell cycle and apoptosis may represent a surveillance system that guarantees the precocious elimination after ovulation of oocytes with a low ability to support normal fertilization and embryo development.

Even though results on animal models should be interpreted with caution, our findings are relevant to both the knowledge and the treatment of human subfertility associated with aging. Indeed, it is known that older couples are likely to be exposed to an increased risk of delayed fertilization because of a decreased coital frequency [49]. Moreover, our observations may be helpful for improving IVF treatment of old patients by encouraging IVF operators to avoid a prolonged interval between oocyte recovery and insemination.

ACKNOWLEDGMENTS

The authors thank the generous technical support of R. De Carolis and G. Ciccone (Animal Care Unit, Faculty of Medicine, University of L'Aquila).

FOOTNOTES

1 Supported by a PRIN grant from Ministero dell'Università e della Ricerca Scientifica e Tecnologica (prot. 2002068388). Back

2 Correspondence. FAX: 39 0862 433433; ctatone{at}univaq.it Back

Received: 28 July 2005.

First decision: 14 August 2005.

Accepted: 24 October 2005.

REFERENCES

  1. te Velde ER, Pearson PL, The variability of female reproductive ageing. Hum Reprod Update 2002 8:141-154[Abstract/Free Full Text]
  2. Ottolenghi C, Uda M, Hamatani T, Crisponi L, Garcia JE, Ko M, Pilia G, Sforza C, Schlessinger D, Forabosco A, Aging of oocyte, ovary, and human reproduction. Ann N Y Acad Sci 2004 1034:117-131[CrossRef][Medline]
  3. Sauer MV, Paulson RJ, Lobo RA, A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med 1990 323:1157-1160[Abstract]
  4. Pellestor F, Andreo B, Arnal F, Humeau C, Demaille J, Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum Genet 2003 112:195-203[CrossRef][Medline]
  5. Battaglia DE, Goodwin P, Klein NA, Soules MR, Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod 1996 11:2217-2222[Abstract/Free Full Text]
  6. Eichenlaub-Ritter U, Boll I, Nocodazole sensitivity age-related aneuploidy, and alterations in the cell cycle during maturation of mouse oocytes. Cytogenetic Cell Genet 1989 52:170-176
  7. Sakurada K, Ishikawa H, Endo A, Cytogenetic effects of advanced maternal age and delayed fertilization on first-cleavage mouse embryos. Cytogenet Cell Genet 1996 72:46-49[Medline]
  8. Zuccotti M, Boiani M, Garagna S, Redi CA, Analysis of aneuploidy rate in antral and ovulated mouse oocytes during female aging. Mol Reprod Dev 1998 50:305-12[CrossRef][Medline]
  9. Liu L, Keefe DL, Nuclear origin of aging-associated meiotic defects in senescence-accelerated mice. Biol Reprod 2004 71:1724-1729[Abstract/Free Full Text]
  10. Eichenlaub-Ritter U, Vogt E, Yin H, Gosden R, Spindles, mitochondria and redox potential in ageing oocytes. Reprod Biomed Online 2004 8:45-58[Medline]
  11. Steuerwald N, Cohen J, Herrera RJ, Sandalinas M, Brenner CA, Association between spindle assembly checkpoint expression and maternal age in human oocytes. Mol Hum Reprod 2001 7:49-55[Abstract/Free Full Text]
  12. Wu J, Zhang L, Wang X, Maturation and apoptosis of human oocytes in vitro are age-related. Fertil Steril 2000 74:1137-1141[CrossRef][Medline]
  13. Tarin JJ, Perez-Albala S, Cano A, Cellular and morphological traits of oocytes retrieved from aging mice after exogenous ovarian stimulation. Biol Reprod 2001 65:141-150[Abstract/Free Full Text]
  14. Hamatani T, Falco G, Carter MG, Akutsu H, Stagg CA, Sharov AA, Dudekula DB, VanBuren V, Ko MS, Age-associated alteration of gene expression patterns in mouse oocytes. Hum Mol Genet 2004 13:2263-78[Abstract/Free Full Text]
  15. Fujino Y, Ozaki K, Yamamasu S, Ito F, Matsuoka I, Hayashi E, Nakamura H, Ogita S, Sato E, Inoue M, DNA fragmentation of oocytes in aged mice. Hum Reprod 1996 11:1480-1483[Abstract/Free Full Text]
  16. Tarin JJ, Perez-Albala S, Cano A, Consequences on offspring of abnormal function in ageing gametes. Hum Reprod Update 2000 6:532-549[Abstract/Free Full Text]
  17. Fissore RA, Kurokawa M, Knott J, Zhang M, Smyth J, Mechanisms underlying oocyte activation and post-ovulatory ageing. Reproduction 2002 124:745-754[Abstract]
  18. Ducibella T, Biochemical and cellular insights into the temporal window of normal fertilization. Theriogenology 1998 49:53-65[CrossRef][Medline]
  19. Xu Z, Abbott A, Kopf GS, Schultz RM, Ducibella T, Spontaneous activation of ovulated mouse oocytes: time-dependent effects on M-phase exit, cortical granule exocytosis, maternal messenger ribonucleic acid recruitment, and inositol 1,4,5-trisphosphate sensitivity. Biol Reprod 1997 57:743-770[Abstract]
  20. Abbott AL, Xu Z, Kopf GS, Ducibella T, Schultz RM, In vitro culture retards spontaneous activation of cell cycle progression and cortical granule exocytosis that normally occur in in vivo unfertilized mouse oocytes. Biol Reprod 1998 59:1515-1521[Abstract/Free Full Text]
  21. Ma W, Zhang D, Hou Y, Li YH, Sun QY, Sun XF, Wang WH, Reduced expression of MAD2, BCL2, and MAP kinase activity in pig oocytes after in vitro aging are associated with defects in sister chromatid segregation during meiosis II and embryo fragmentation after activation. Biol Reprod 2005 72:373-383[Abstract/Free Full Text]
  22. Jones KT, Turning it on and off: M-phase promoting factor during meiotic maturation and fertilization. Mol Hum Reprod 2004 10:1-5[Abstract/Free Full Text]
  23. Fan HY, Sun QY, Involvement of mitogen-activated protein kinase cascade during oocyte maturation and fertilization in mammals. Biol Reprod 2004 70:535-547[Abstract/Free Full Text]
  24. Gordo AC, Rodrigues P, Kurokawa M, Jellerette T, Exley GE, Warner C, Fissore R, Intracellular calcium oscillations signal apoptosis rather than activation in in vitro aged mouse eggs. Biol Reprod 2002 66:1828-1837[Abstract/Free Full Text]
  25. Vander Heiden MG, Thompson CB, BCL-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?. Nat Cell Biol 1999 1:209-216
  26. Thomenius MJ, Distelhorst CW, Bcl-2 on the endoplasmic reticulum: protecting the mitochondria from a distance. J Cell Sci 2003 116:4493-4499[Abstract/Free Full Text]
  27. Oltvai ZN, Milliman CL, Korsmeyer SJ, BCL-2 heterodimerizes in vitro with a conserved homology, Bax, that accelerates programmed cell death. Cell 1993 74:609-619[CrossRef][Medline]
  28. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227:680-685[CrossRef][Medline]
  29. Negrini M, Silini E, Kozak CA, Tsujimoto Y, Croce CM, Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell 1987 49:455-463[CrossRef][Medline]
  30. Nicolson GL, Yanagimachi R, Yanagimachi H, Ultrastructural localization of lectin-binding sites on the zonae pellucidae and plasma membranes of mammalian eggs. J Cell Biol 1975 66:263-274[Abstract/Free Full Text]
  31. Favata MF, et al Identification of a novel inhibitor of mitogen-activated protein kinase. J Biol Chem 1998 273:18623-632[Abstract/Free Full Text]
  32. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP, Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 1997 243:527-536[Medline]
  33. Phillips KP, Petrunewich MA, Collins JL, Booth RA, Liu XJ, Baltz JM, Inhibition of MEK or cdc2 kinase parthenogenetically activates mouse eggs and yields the same phenotypes as Mos(–/–) parthenogenotes. Dev Biol 2002 247:210-223[CrossRef][Medline]
  34. Gotoh Y, Cooper JA, Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. J Biol Chem 1998 273:17477-17482[Abstract/Free Full Text]
  35. Huot J, Houle F, Marceau F, Landry J, Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 1997 80:383-392[Abstract/Free Full Text]
  36. Ling YH, Tornos C, Perez-Soler R, Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J Biol Chem 1998 273:18984-18991[Abstract/Free Full Text]
  37. Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM, Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med 1999 189:1815-1822[Abstract/Free Full Text]
  38. Breitschopf K, Haendeler J, Malchow P, Zeiher AM, Dimmeler S, Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol 2000 20:1886-1896[Abstract/Free Full Text]
  39. Du L, Lyle CS, Obey TB, Gaarde WA, Muir JA, Bennett BL, Chambers TC, Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J Biol Chem 2004 279:11957-11966[Abstract/Free Full Text]
  40. Kikuchi K, Naito K, Noguchi J, Kaneko H, Tojo H, Maturation/M-phase promoting factor regulates aging of porcine oocytes matured in vitro. Cloning Stem Cells 2002 4:211-222[CrossRef][Medline]
  41. Tashker JS, Olson M, Kornbluth S, Post-cytochrome C protection from apoptosis conferred by a MAPK pathway in Xenopus egg extracts. Mol Biol Cell 2002 13:393-401[Abstract/Free Full Text]
  42. Faure S, Vigneron S, Doree M, Morin N, A member of the Ste20/PAK family of protein kinases is involved in both arrest of Xenopus oocytes at G2/prophase of the first meiotic cell cycle and in prevention of apoptosis. EMBO J 1997 16:5550-5561[CrossRef][Medline]
  43. Gandolfi TA, Gandolfi F, The maternal legacy to the embryo: cytoplasmic components and their effects on early development. Theriogenology 2001 55:1255-1276[CrossRef][Medline]
  44. Jurisicova A, Acton BM, Deadly decisions: the role of genes regulating programmed cell death in human preimplantation embryo development. Reproduction 2004 128:281-291[Abstract/Free Full Text]
  45. Van Blerkom J, Intrafollicular influences on human oocyte developmental competence: perifollicular vascularity, oocyte metabolism and mitochondrial function. Hum Reprod 2000 15:173-188
  46. de Bruin JP, Dorland M, Spek ER, Posthuma G, van Haaften M, Looman CW, te Velde ER, Age-related changes in the ultrastructure of the resting follicle pool in human ovaries. Biol Reprod 2004 70:419-424[Abstract/Free Full Text]
  47. Tarin JJ, Gomez-Piquer V, Pertusa JF, Hermenegildo C, Cano A, Association of female aging with decreased parthenogenetic activation, raised MPF, and MAPKs activities and reduced levels of glutathione S-transferases activity and thiols in mouse oocytes. Mol Reprod Dev 2004 69:402-410[CrossRef][Medline]
  48. Carbone MC, Tatone C, Delle Monache S, Marci R, Caserta D, Colonna R, Amicarelli F, Antioxidant enzymatic defences in human follicular fluid: characterization and age-dependent changes. Mol Hum Reprod 2003 9:639-643[Abstract/Free Full Text]
  49. Simpson JL, et al Pregnancy outcome associated with natural family planning (NFP): scientific basis and experimental design for an international cohort study. Adv Contracept 1988 4:247-64[CrossRef][Medline]



This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
K. T. Jones
Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age
Hum. Reprod. Update, March 1, 2008; 14(2): 143 - 158.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
C. Tatone, F. Amicarelli, M. C. Carbone, P. Monteleone, D. Caserta, R. Marci, P. G. Artini, P. Piomboni, and R. Focarelli
Cellular and molecular aspects of ovarian follicle ageing
Hum. Reprod. Update, March 1, 2008; 14(2): 131 - 142.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J.-C. Huang, L.-Y. Yan, Z.-L. Lei, Y.-L. Miao, L.-H. Shi, J.-W. Yang, Q. Wang, Y.-C. Ouyang, Q.-Y. Sun, and D.-Y. Chen
Changes in Histone Acetylation During Postovulatory Aging of Mouse Oocyte
Biol Reprod, October 1, 2007; 77(4): 666 - 670.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
74/2/395    most recent
biolreprod.105.046169v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tatone, C.
Right arrow Articles by Amicarelli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tatone, C.
Right arrow Articles by Amicarelli, F.
Agricola
Right arrow Articles by Tatone, C.
Right arrow Articles by Amicarelli, F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS